• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, April 1, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Researchers create new programmed shape-morphing scaffolds enabling facile 3-D endothelialization

Bioengineer by Bioengineer
June 1, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: DU Xuemin

Recently, a research team led by Dr. DU Xuemin at the Shenzhen Institutes of Advanced Technology (SIAT) of the Chinese Academy of Sciences created a new shape-morphing scaffold, enabling programmed deformation from a 2D planar cell-laden structure to a well-defined 3D tubular shape, which facilitated the facile 3D endothelialization of small-diameter vascular grafts.

The paper entitled "Programmed Shape-Morphing Scaffolds Enabling Facile 3D Endothelialization" was published in Advanced Functional Materials.

Cardiovascular disease is now the No. 1 cause of death globally according to the World Health Organization, and more than 17.5 million patients die from it every year.

Coronary artery bypass grafting (CABG) is one of most effective approaches for treating severe cardiovascular disease. However, patients undergoing CABG still face the high risks of transplantation surgery and potential complications caused by compliance mismatch.

In recent years, tissue engineering has emerged, holding the promise of constructing functional vascular analogs for treating cardiovascular disease. Nevertheless, 3D endothelialization remains a great challenge for tissue-engineered vascular grafts (TEVGs), particularly small-diameter ones (diameter To address the problem of 3D endothelialization of TEVGs, the researchers designed and developed a novel scaffold, consisting of two layers that combined a shape memory polymer and an electrospun membrane.

By employing the unique shape memory property of the polymer, the scaffold could deform from a 2D planar shape to a well-defined 3D tubular shape at the physiological temperature (37 °C).

The endothelial cells seeded firmly and homogeneously on the electrospun membrane of the planar bilayer scaffold could therefore be conveniently converted to a vascular-like structure of predetermined tubular shape, and a desirable 3D spatial organization of endothelial cells onto the lumen of the scaffold was achieved.

The study found that the 3D cultured endothelial cells on the novel shape-morphing scaffold could form biomimetic cell-scaffold and cell-cell interactions, effectively promoting the formation of a confluent endothelial monolayer and the 3D endothelialization of TEVGs.

This research not only offers a new method for creating TEVGs that enables facile 3D endothelialization, but also offers a potential in vitro endothelium model for the screening of cardiovascular drugs.

"We hope that the universal strategy developed in this study by combining smart materials and conventional tissue engineering scaffolds can be extended to engineering complex cell-scaffold constructs mimicking the complicated anatomy of various tissues and organs through on-demand programmed deformation," said Dr. DU Xuemin.

###

Media Contact

ZHANG Xiaomin
[email protected]
86-755-865-85299

http://english.cas.cn/

Related Journal Article

http://dx.doi.org/10.1002/adfm.201801027

Share14Tweet8Share2ShareShareShare2

Related Posts

Loss of Luminal Lineage Fuels Resistance to ERα Antagonists

April 1, 2026

Adults with Unknown Autoinflammation Mimic Still’s Disease

April 1, 2026

Excess Pancreatic Fat in Obese Youth Associated with Increased Cardiometabolic Health Risks

April 1, 2026

Questions Raised About the Efficacy of Popular ‘KT-Tape’ in Relieving Joint and Muscle Pain and Enhancing Mobility

April 1, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    96 shares
    Share 38 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1006 shares
    Share 398 Tweet 249
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    43 shares
    Share 17 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Creating Desktop Particle Accelerators to Open New Frontiers in Scientific Research

Do Your Genes Influence How Lifestyle Choices Affect Aging?

Urban Systems and Traffic: Unequal Two-Way Links

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.